Athira Pharma

5 Neuro Data Readouts to Watch in the Second Half of 2024
BioSpace
Mon, 07/15/24 - 11:43 am
neurology
clinical trials
Athira Pharma
fosgonimeton
Alzheimer's disease
AbbVie
Cerevel Therapeutics
emraclidine
schizophrenia
Neumora Therapeutics
major depressive disorder
navacaprant
Amylx
AMX003
Wolfram syndrome
Vigil Neuroscience
iluzanebart
Athira’s losing streak continues with phase 2 failure in dementia
Fierce Biotech
Tue, 12/12/23 - 11:09 am
Athira Pharma
clinical trials
dementia
fosgonimeton
Athira’s Alzheimer’s Therapy Climbs Ranks in a Competitive Space
BioSpace
Fri, 12/2/22 - 11:08 am
Athira Pharma
Alzheimer's disease
fosgonimeton
Sometimes, Clinical Trials Miss the Mark: Neurocrine, Akebia, Eliem and Athira
BioSpace
Fri, 08/5/22 - 10:57 am
clinical trials
Neurocrine Biosciences
Akebia Therapeutics
Eliem Therapeutics
Athira Pharma
Athira Puts Positive Spin on Alzheimer’s Trial Despite Missed Endpoint
BioSpace
Wed, 06/22/22 - 10:28 am
Athira Pharma
fosgonimeton
Alzheimer's disease
clinical trials
Significant readouts for small players
EP Vantage
Thu, 03/31/22 - 10:22 am
clinical trials
SAGE Therapeutics
Biogen
Relmada
Athira Pharma
TauRx
Athira Looks to Advance Alzheimer’s, Parkinson’s Disease Research Amid CEO Debacle
BioSpace
Wed, 08/18/21 - 11:01 am
Athira Pharma
CEO
Alzheimer's disease
Parkinson's Disease
R&D
Athira Pharma in Crosshairs of Legal Action Over Data Manipulation Charges
BioSpace
Thu, 08/5/21 - 11:03 pm
Athira Pharma
data manipulation
Athira Pharma CEO placed on leave after questions about her doctoral research, shares sink more than 30%
Geekwire
Fri, 06/18/21 - 10:20 am
Athira Pharma
Leen Kawas
Pharma CEOs
Seattle-based Athira, aiming for tough Alzheimer's and Parkinson's targets, raises $204M fo
Endpoints
Fri, 09/18/20 - 10:58 am
Athira Pharma
IPOs
Alzheimer's disease
Parkinson's Disease
Athira Aims for the Nasdaq to Advance Alzheimer’s Drug to Phase 2 Tests
Xconomy
Thu, 08/27/20 - 10:25 pm
Athira Pharma
Alzheimer's disease
clinical trials
ATH-1017
Can a small biotech successfully tackle an Everest climb like Alzheimer’s? Athira has $85M and some influential backers ready to give it a shot
Endpoints
Sat, 06/6/20 - 03:08 pm
Alzheimer's disease
Athira Pharma
clinical trials
Alzheimer's-focused M3 Biotechnology rebrands as Athira Pharma
Fierce Biotech
Fri, 04/12/19 - 12:04 am
M3 Biotechnology
rebranding
Athira Pharma
Alzheimer's disease